|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hadassah Medical Organization |
| Information provided by: | Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT00478998 |
Purpose
The purpose of this study is to see whether patients undergoing ESWL, for upper tract urinary stones between 1.5-2.0cm, may be treated by expulsion therapy(Tamsulosin) instead of inserting ureteral stents .
| Condition | Intervention | Phase |
|
Upper Tract Ureterolithiasis |
Drug: Tamsulosin |
Phase II |
| ChemIDplus related topics: | Tamsulosin Tamsulosin hydrochloride |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment |
| Official Title: | Phase II Study Comparing Two Groups of Patients Undergoing ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin |
Eligibility
| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Mordechai Duvdevani, MD | 0508946816 | moti_duv@yahoo.com |
| Contact: Shilo Rosenberg, MD | 0508946036 | shilo_inbar@bezeqint.net |
| Israel | |||||
| Hadassah Medical Organization | Not yet recruiting | ||||
| Jerusalem, Israel, 91120 | |||||
| Contact: Mordechai Duvdevani, MD 0508946816 moti_duv@yahoo.com | |||||
| Principal Investigator: Mordechai Duvdevani, MD | |||||
| Hadassah Medical Organization |
| Principal Investigator: | Mordechai Duvdevani, MD | Hadassah Medical Organization |
More Information
| Study ID Numbers: | 890pal- HMO-CTIL |
| First Received: | May 24, 2007 |
| Last Updated: | May 24, 2007 |
| ClinicalTrials.gov Identifier: | NCT00478998 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|
|